(Q52978048)

English

A phase I study of gemcitabine, 5-fluorouracil and leucovorin in patients with advanced, recurrent, and/or metastatic solid tumors.

scientific article published in January 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/10426665

A phase I study of gemcitabine, 5-fluorouracil and leucovorin in patients with advanced, recurrent, and/or metastatic solid tumors. (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/10426665

1 reference

based on heuristic

inferred from title

author name string

Berlin JD

1

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/10426665

Alberti DB

2

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/10426665

Arzoomanian RZ

3

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/10426665

Feierabend CA

4

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/10426665

Simon KJ

5

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/10426665

Binger KA

6

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/10426665

Marnocha RM

7

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/10426665

Wilding G

8

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/10426665

publication date

1 January 1998

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/10426665

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/10426665

16

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/10426665

4

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/10426665

325-330

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/10426665

https://scigraph.springernature.com/pub.10.1023/a:1006242005837

0 references

Laboratory and clinical studies of biochemical modulation by hydroxyurea

1 reference

https://pubmed.ncbi.nlm.nih.gov/10426665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advanced breast cancer: a phase II trial with gemcitabine

1 reference

https://pubmed.ncbi.nlm.nih.gov/10426665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo potentiation of 5-fluorouracil cytotoxicity against AKR leukemia by purines, pyrimidines, and their nucleosides and deoxynucleosides

1 reference

https://pubmed.ncbi.nlm.nih.gov/10426665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Action of 2',2'-difluorodeoxycytidine on DNA synthesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10426665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New vistas for leucovorin in cancer chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10426665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preclinical and clinical evaluation of 5-fluorouracil biochemical modulation with folinic acid and hydroxyurea for patients with colorectal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10426665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2',2'-difluorodeoxycytidine

1 reference

https://pubmed.ncbi.nlm.nih.gov/10426665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10426665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10426665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytotoxicity and DNA fragmentation associated with sequential gemcitabine and 5-fluoro-2'-deoxyuridine in HT-29 colon cancer cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10426665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemcitabine: a modulator of intracellular nucleotide and deoxynucleotide metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/10426665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/10426665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1006242005837

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/10426665

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/10426665

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52978048&oldid=1584729809"